Britannia Life Sciences Inc (TSE:BLAB) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Britannia Life Sciences Inc. has reported a revenue increase to $7.6 million and an adjusted EBITDA of $1.7 million for fiscal year 2024. The company also highlighted the strategic launch of its PhotonAssayTM units in Ontario and British Columbia, as well as a successful private placement raising $932,000, signaling expansion and technological advancements in mineral analysis.
For further insights into TSE:BLAB stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue